Chronic Lymphocytic Leukemia working group



Prof. Dr. A. P. Kater (AmsterdamUMC – AMC, Amsterdam)


Dr. M.D. Levin (Albert Schweitzer Hospital, Dordrecht)


Dr. D. te Raa (Gelderse Vallei, Ede)


Dr. R. Mous (UMCU, Utrecht)

Chief protocol

Dr. S. Kersting (Hagaziekenhuis, Den Haag)

Key objectives of working group

The key objectives of this working group are:

  • To initiate and implement (inter)national multicenter phase (I/)II and III clinical studies for CLL patients
  • To partner in Intergroup studies, with key partners: Nordic CLL SG, and the German CLL SG
  • To partner with pharma initiated studies only if the working group has a clear and recognizable role
  • To co-develop and recommend certified diagnostics in the Netherlands
  • To participate in the ERIC (European Research Initiative on CLL)
  • To develop guidelines for diagnosis and treatment of CLL and related disorders
  • To guide reimbursement issues
  • To initiate and implement healthcare innovations

CLL associated studies

A list of HOVON associated CLL studies can be found here 

Research on CLL samples

For the CLL working group members it is possible to request to perform analyses on the samples taken from CLL patients and stored in the biobank. Please find below the regulations of this biobank and the usage of the samples

CLL biobank regulations

Publication overview

Meetings & Minutes

Please note the section where meetings dates & minutes are shown are only accessible after log in.

This content is restricted. Please log in.
This content is restricted. Please log in.